# A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Study · id `cardio:ct-nct01958957` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01958957](<https://clinicaltrials.gov/study/NCT01958957>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01958957

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 6300 participants.

## Technical summary

Registry record NCT01958957. Allocation not applicable; no masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2014-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 6300 participants (enrolled count; ClinicalTrials.gov record NCT01958957, source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT01958957, source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)
- Primary completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01958957, source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)
- Completion: 2014-10 (actual) (ClinicalTrials.gov record NCT01958957, source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT01958957, source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01958957-2014-12-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
- Condition: Ischemic Stroke
- Intervention (Drug): Ginkgolides Meglumine Injection
- Lead sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd
- Lead sponsor class: INDUSTRY
- Collaborator: Beijing Bionovo Medicine Development Co., Ltd.
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 338e0e9aa3db2437d80787f3f5be67d67964e4d5d7937871b64a5d75617b206f
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
